Mayo Clinic
The Paul F. Glenn Laboratories for Senescence Research at Mayo Clinic represent a collaboration among four labs within the Cellular Senescence Program that engage in aging-related research. Specifically, the four labs explore how age-related diseases and disorders are affected by senescent cells and how eliminating senescent cells could improve health and extend both life span and health span, the healthy, productive time in life. Mayo Clinic researchers have found that inhibition of senescence or disposal of senescent cells delays or slows several age-related pathologies with no overt side effects. This discovery opened a new field of senescent cell research that the Glenn Laboratories will help advance, potentially leading to new therapies for age-related diseases.
